Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes.
暂无分享,去创建一个
S. Yamashita | T. Tsukazaki | Akihiko Yonekura | Y. Miyazaki | S Yamashita | Y Miyazaki | T Tsukazaki | Y Hirota | A Yonekura | M Osaki | H Shindo | A. Yonekura | H. Shindo | S. Yamashita | M. Osaki | Y. Hirota | Y. Miyazaki | Youichi Miyazaki
[1] W. B. van den Berg,et al. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[2] P. Hoodless,et al. Mechanism and Function of Signaling by the TGFβ Superfamily , 1998 .
[3] R. Todhunter,et al. Effect of methylprednisolone and mechanical loading on canine articular cartilage in explant culture. , 1996, Osteoarthritis and cartilage.
[4] J. Pujol,et al. Expression of decorin and biglycan by rabbit articular chondrocytes. Effects of cytokines and phenotypic modulation. , 1998, Biochimica et biophysica acta.
[5] Jeffrey L. Wrana,et al. TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.
[6] V. Lefebvre,et al. An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes , 1996, Molecular and cellular biology.
[7] H. Inada,et al. Interactions between steroid hormones and insulin-like growth factor-I in rabbit chondrocytes. , 1991, Endocrinology.
[8] S. Yamashita,et al. Regulation of c-fos gene induction and mitogenic effect of transforming growth factor-beta1 in rat articular chondrocyte. , 1999, Endocrine journal.
[9] H. Sugiya,et al. Transforming growth factor‐β1 regulation of bone sialoprotein gene transcription: Identification of a TGF‐β activation element in the rat BSP gene promoter , 1997 .
[10] R. Treisman,et al. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain , 1993, Cell.
[11] H. Moses,et al. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.
[12] M. Zafarullah,et al. Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-beta and dexamethasone in bovine and human articular chondrocytes. , 1996, DNA and cell biology.
[13] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[14] S. Kliewer,et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor , 1990, Cell.
[15] J. Raynauld,et al. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. , 1994, Arthritis and rheumatism.
[16] P. Herrlich,et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP‐1. , 1994, The EMBO journal.
[17] Véronique Lefebvre,et al. A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.
[18] E B Hunziker,et al. Differential effects of IGF-1 and TGF beta-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. , 1998, Osteoarthritis and cartilage.
[19] H. Namba,et al. Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. , 1999, Endocrine journal.
[20] W. Horton,et al. In vivo cartilage formation from growth factor modulated articular chondrocytes. , 1998, Clinical orthopaedics and related research.
[21] Patrick P.L. Tam,et al. SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.
[22] M. Pfahl. Nuclear receptor/AP-1 interaction. , 1993, Endocrine reviews.
[23] J. Elias,et al. Dexamethasone regulation of lung epithelial cell and fibroblast interleukin-11 production. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[24] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[25] Sporn,et al. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. , 1988, The Journal of biological chemistry.
[26] J. Visser,et al. Downstream factors in transforming growth factor-β family signaling , 1998, Molecular and Cellular Endocrinology.
[27] M. Karin. The regulation of AP-1 activity by mitogen-activated protein kinases. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[28] Jeffrey L. Wrana,et al. TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.
[29] H. Namba,et al. Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. , 1994, Experimental cell research.
[30] A. Cato,et al. Molecular mechanisms of anti‐inflammatory action of glucocorticoids , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[31] J. Massagué. TGFβ Signaling: Receptors, Transducers, and Mad Proteins , 1996, Cell.
[32] Xin Chen,et al. A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.
[33] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[34] J. Raynauld,et al. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. , 1995, Laboratory investigation; a journal of technical methods and pathology.